Thrombus-related focal in-stent restenosis after everolimus-eluting stent implantation

被引:0
|
作者
Tomohiro Hayashi
Jun-ichi Kotani
Hatsue Ishibashi-Ueda
Satoshi Yasuda
机构
[1] National Cerebral and Cardiovascular Center,Cardiovascular Division
来源
Heart and Vessels | 2014年 / 29卷
关键词
Drug-eluting stent; In-stent restenosis; Imaging;
D O I
暂无
中图分类号
学科分类号
摘要
A 60-year-old man who had received repeated angioplasty for silent ischemia was suspected to have restenosis based on radioisotope imaging (exercise-RI) findings 6 months after everolimus-eluting stent (EES) implantation (3.5 × 28, 3.5 × 28, 3.0 × 18 mm). The stents had been implanted for chronic total occlusion of the right coronary artery (RCA), and the patient was on continuous dual antiplatelet therapy. Diagnostic angiography demonstrated in-stent restenosis in the proximal RCA, which was treated by optical coherence tomography (OCT)-guided cutting balloon angioplasty with distal protection. OCT findings of the stenotic segment before angioplasty showed that the lesion had complex features. The lesion was successfully dilated, and whitish material obtained by a distal protection device was composed of fibrin thrombi with neutrophils and small pieces of mature fibrocellular neointima. The mechanisms and patterns of restenosis after EES placement have not been well clarified. This case may reflect a restenosis pattern (i.e., asymptomatic, focal, and thrombi-related) in the era of the newer generation of drug-eluting stents.
引用
收藏
页码:273 / 277
页数:4
相关论文
共 50 条
  • [11] Effect of Rivaroxaban and Clopidogrel Combination Therapy on In-Stent Responses After Everolimus-Eluting Stent Implantation in a Porcine Coronary Model
    Kitano, Daisuke
    Migita, Suguru
    Li, Yuxin
    Takahashi, Rie
    Taniguchi, Yoshiki
    Kurosawa, Takafumi
    Sudo, Mitsumasa
    Haruta, Hironori
    Hiro, Takafumi
    Takayama, Tadateru
    Mitsumata, Masako
    Matsumoto, Taro
    Okumura, Yasuo
    Hirayama, Atsushi
    JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS, 2022, 29 (01) : 69 - 81
  • [12] Post-intervention minimal stent area as a predictor of target lesion revascularization after everolimus-eluting stent implantation for in-stent restenosis: a single-center observational study
    Fujita, Takanari
    Takeda, Teruki
    Hano, Yoshifumi
    Takashima, Noriyuki
    Yamaji, Masayuki
    Sakaguchi, Tomoko
    Maeda, Keiko
    Mabuchi, Hiroshi
    Murakami, Tomoyuki
    Morimoto, Takeshi
    Kimura, Takeshi
    CORONARY ARTERY DISEASE, 2019, 30 (06) : 432 - 439
  • [13] Paclitaxel-eluting balloon versus everolimus-eluting stent in patients with diabetes mellitus and in-stent restenosis: Insights from the randomized DARE trial
    Claessen, Bimmer E.
    Henriques, Jose P. S.
    Vendrik, Jeroen
    Boerlage-van Dijk, Kirsten
    van der Schaaf, Rene J.
    Meuwissen, Martijn
    van Royen, Niels
    Gosselink, A. T. Marcel
    van Wely, Marleen H.
    Dirkali, Atilla
    Arkenbout, E. Karin
    Piek, Jan. J.
    Baan, Jan, Jr.
    CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2019, 93 (02) : 216 - 221
  • [14] Impact of Hinge Motion on In-Stent Restenosis After Sirolimus-Eluting Stent Implantation
    Ino, Yasushi
    Kubo, Takashi
    Kitabata, Hironori
    Shimamura, Kunihiro
    Shiono, Yasutsugu
    Orii, Makoto
    Okochi, Keishi
    Sougawa, Hiromichi
    Tanimoto, Takashi
    Komukai, Kenichi
    Ishibashi, Kohei
    Takarada, Shigeho
    Nakanishi, Hiroko
    Tanaka, Atsushi
    Kimura, Keizo
    Hirata, Kumiko
    Mizukoshi, Masato
    Imanishi, Toshio
    Akasaka, Takashi
    CIRCULATION JOURNAL, 2011, 75 (08) : 1878 - 1884
  • [15] Preserved endothelial vasomotor function after everolimus-eluting stent implantation
    Roura, Gerard
    Homs, Silvia
    Luis Ferreiro, Jose
    Gomez-Lara, Josep
    Romaguera, Rafael
    Teruel, Luis
    Sanchez-Elvira, Guillermo
    Ariza-Sole, Albert
    Antoni Gomez-Hospital, Joan
    Cequier, Angel
    EUROINTERVENTION, 2015, 11 (06) : 643 - 649
  • [16] Optimal treatment of recurrent restenosis lesions after drug-eluting stent implantation for in-stent restenosis lesions
    Kubo, Shunsuke
    Kadota, Kazushige
    Otsuru, Suguru
    Hasegawa, Daiji
    Shigemoto, Yoshikazu
    Habara, Seiji
    Tada, Takeshi
    Tanaka, Hiroyuki
    Fuku, Yasushi
    Katoh, Harumi
    Goto, Tsuyoshi
    Mitsudo, Kazuaki
    EUROINTERVENTION, 2013, 9 (07) : 788 - 796
  • [17] Mechanisms of In-Stent Restenosis After Drug-Eluting Stent Implantation Intravascular Ultrasound Analysis
    Kang, Soo-Jin
    Mintz, Gary S.
    Park, Duk-Woo
    Lee, Seung-Whan
    Kim, Young-Hak
    Lee, Cheol Whan
    Han, Ki-Hoon
    Kim, Jae-Joong
    Park, Seong-Wook
    Park, Seung-Jung
    CIRCULATION-CARDIOVASCULAR INTERVENTIONS, 2011, 4 (01) : 9 - 14
  • [18] Risk of in-stent thrombus formation at one year after drug-eluting stent implantation
    Higo, Tomoaki
    Ueda, Yasunori
    Matsuo, Koshi
    Nishio, Mayu
    Hirata, Akio
    Asai, Mitsutoshi
    Nemoto, Takayoshi
    Murakami, Ayaka
    Kashiwase, Kazunori
    Kodama, Kazuhisa
    THROMBOSIS RESEARCH, 2011, 128 (05) : 431 - 434
  • [19] Late-phase inflammatory response as a feature of in-stent restenosis after drug-eluting stent implantation
    Yoneda, Shuichi
    Abe, Shichiro
    Kanaya, Tomoaki
    Oda, Kazuhiko
    Nishino, Setsu
    Kageyama, Michiya
    Taguchi, Isao
    Masawa, Nobuhide
    Inoue, Teruo
    CORONARY ARTERY DISEASE, 2013, 24 (05) : 368 - 373
  • [20] Coexistent In-Stent Restenosis, Late Incomplete Stent Apposition and Mural Thrombus in a Zotarolimus-Eluting Stent
    Zhang, Feng
    Qian, Juying
    Ge, Junbo
    JOURNAL OF INVASIVE CARDIOLOGY, 2008, 20 (08): : 423 - 425